Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
BioCryst Pharmaceuticals, Inc. (BCRX) had Operating Cash Flow per Share of $0.06 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$163.35M |
|
$5.08M |
|
$2.80M |
|
$160.56M |
|
$133.57M |
|
$29.79M |
|
$-23.30M |
|
$6.49M |
|
$6.49M |
|
$5.08M |
|
$5.08M |
|
$5.08M |
|
$5.08M |
|
$29.79M |
|
$28.96M |
|
209.52M |
|
219.89M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$398.46M |
|
$8.46M |
|
$58.73M |
|
$457.19M |
|
$177.16M |
|
$692.68M |
|
$701.62M |
|
$878.78M |
|
$-421.59M |
|
$-421.59M |
|
$-421.59M |
|
209.91M |
|
| Cash Flow Statement Financials | |
$13.79M |
|
$56.22M |
|
$-73.16M |
|
$-15.06M |
|
$-16.40M |
|
$-1.34M |
|
$42.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.25 |
|
-- |
|
-- |
|
2.56 |
|
-1.73 |
|
98.29% |
|
18.23% |
|
18.23% |
|
-- |
|
3.97% |
|
3.11% |
|
$13.46M |
|
-- |
|
-- |
|
-- |
|
0.36 |
|
0.55 |
|
1.79 |
|
50.23 |
|
-1.21% |
|
-1.21% |
|
1.11% |
|
1.88% |
|
$-2.01 |
|
$0.06 |
|
|
Operating Cash Flow per Share |
$0.06 |